10 November 2025 in International Journal of Surgery
Background: Histotripsy is an innovative, non-invasive ultrasound-based technology that mechanically disrupts liver tumor tissues at the cellular level through acoustic cavitation. It offered precise tissue destruction with minimal collateral damage. This study evaluated the safety and efficacy of this novel treatment through clinical and biomolecular analysis. Methods: From August to 30 December 2024 patients with malignant liver cancers, Child-Pugh A liver function, and tumors <10 cm were recruited. Treatments were performed under general anesthesia using histotripsy with tailored approaches for left and right liver tumors. Technical success and treatment efficacy were assessed by contrast-enhanced MRI at 36 hours and 1 month post-procedure. Complications were classified by Clavien-Dindo criteria. Plasma cytokine profiles were analyzed pre-treatment, at 1-day, and 1-month post-treatment. A cytokine score predictive of clinical outcomes was derived via Least Absolute Shrinkage and Selection Operator regression and Receiver Operating Characteristic analysis. Results: A total of 19 patients (63.3%) had hepatocellular carcinoma while the remaining 11 patients had liver metastases from different origins including colorectal, pancreas, breast, and thyroid. A total of sixty tumors with a median tumor diameter of 1.8 cm and a median tumor number per patient of 2 were treated. The 36-hour technical success rate was 95% and 1-month efficacy rate was 82.5%. Procedure-related complications were mild, including transient fever and abdominal discomfort controlled by analgesics; no grade III or above complications occurred. Cytokine profiling revealed a significant systemic inflammatory response at 1-day post-treatment, notably increased Interleukin 6 (IL-6). A four-cytokine panel (IL-7, IL-6, IL-1α, CXCL1) generated a cytokine score that strongly predicted complete tumor response (area under the curve = 0.955). Higher cytokine scores correlated with greater treatment volume and elevated liver enzymes indicative of an immunomodulatory effect. Conclusion: Histotripsy was a safe and effective non-invasive treatment for liver tumors, demonstrating promising clinical outcomes and systemic immune activation. These findings supported further investigation into its long-term efficacy and potential synergy with immunotherapy.
17 July 2019 in Journal of Clinical Rheumatology and Immunology
Objective: To investigate the associations between age and clinical and radiological disease activities in axial SpA. Methods: One hundred and twenty-one patients fulfilling the Assessment of SpondyloArthritis International Society Classification Criteria for axial SpA were included in analyses. Patient demographics, disease activity and radiographic scores, as well as magnetic resonance imaging (MRI) with diffusion weighted imaging derived apparent diffusion coefficient values (DWI(ADC)), were compared between patients aged > 40 and [ ] 40 years at a cross-sectional level. Variables with significant differences in univariate analyses were used as dependent variables in multivariate linear regression models adjusted for potential confounding/contributing factors. Results: Multivariate analysis showed that increasing age was significantly associated with higher Bath Ankylosing Spondylitis Functional Index (B = 0.04, p < 0.01) and Bath Ankylosing Spondylitis Metrology Index scores (B = 0.04, p < 0.01); as well as higher modified Stoke Ankylosing Spondylitis Spine Score (B = 0.41, p < 0.01). On MRI, increasing age was associated with a lower DWI(ADC) (B = (-0.01), p < 0.01) of the SI joints, but higher DWI(ADC) values of the axial spine (B = 0.01, p = 0.01). Conclusion: Increasing age in SpA was associated with greater functional impairment and structural damage, more inflammation of the axial spine, but less inflammation of the SI joints. Our findings are consistent with the traditional belief that SpA is an “ascending disease” and highlights the importance of different modalities of MRI in the diagnosis and disease monitoring of SpA.
16 December 2024 in Journal of Clinical Rheumatology and Immunology
Objective: To compare the accuracy and reliability of detecting the intensity of spinal inflammation on short tau inversion recovery (STIR) with the apparent diffusion coefficient (ADC) values of the active magnetic resonance imaging (MRI) lesions in axial spondyloarthritis (axSpA). Materials and methods: Fifty active lesions in the STIR sequence of spinal MRI were identified. With reference to sites of active lesions in STIR, the corresponding region of interest (ROI) on the ADC map was drawn to determine the maximum ADC (ADC ), mean ADC (ADC ), normalized maximum (nADC ), and mean (nADC ). Four independent readers scored the identified active lesions as “intense” or “non-intense” according to the Spondyloarthritis Research Consortium of Canada (SPARCC) MRI index. They were compared to various ADC parameters for assessment of accuracy and reliability. Regression analyses were used to adjust potential factors that could affect ADC. Results: Significant differences were found in ADC between “intense” and “non-intense” lesions scored by three of the four readers (1,405.7 ± 271.4 vs. 1,165.8 ± 223.8, = 0.01; 1,420.7 ± 272.1 vs. 1,209.0 ± 248.5, = 0.01; 1,438.0 ± 307.2 vs. 1,213.6 ± 231.0, = 0.01). Only one reader could differentiate a difference in “intense” and “non-intense” lesions with respect to ADC (899.2 ± 248.3 vs. 711.0 ± 222.6, = 0.01) and nADC (4.4 ± 2.1 vs. 3.4 ± 1.4, = 0.05). Inter-reader agreements were slight to moderate (kappa = 0.07–0.45). Reliability substantially improved when only the lowest and highest 25th percentiles of ADC values were included (kappa = 0.17–0.75). Regression analyses showed that the “intense” lesions were associated with higher ADC values after adjustment for confounders. Conclusion: Reading of STIR MRI is limited by the lack of ability in differentiating subtle differences of spinal inflammation. ADC could be an alternative method.